Mark Haas

37.8k citations
288 papers · 30.4k · 26 hit papers · h-index 84

Impact in

  • Transplantation top 0.01%
    • Renal Transplantation Outcomes and Treatments
  • Nephrology top 0.02%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes
    • Acute Kidney Injury Research

Papers in

    • Renal Transplantation Outcomes and Treatments 102
    • Renal Diseases and Glomerulopathies 89
    • Chronic Kidney Disease and Diabetes 11
    • Acute Kidney Injury Research 8

Mark Haas

281 papers receiving 29.5k citations

Mark Haas's Hit Papers

Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation 2024 · 67 citations
670+3+6Years since publication250500750

Peers

Mark Haas
Comparison fields: 5 of 137
  • Transplantation 10.7k
  • Nephrology 9.7k
  • Rheumatology 2k
  • Immunology 2.5k
  • Molecular Biology 2.7k
Replace Charles E. Alpers with:
Charles E. Alpers United States
Surya V. Seshan United States
Lorraine C. Racusen United States
Philip F. Halloran Canada
Joseph Peter Grande United States
Jan J. Weening Netherlands
Helen Liapis United States
Bruce A. Julian United States
Sanjeev M. Sethi United States
Helmut G. Rennke United States
Mark Haas relative to Charles E. Alpers United States Charles E. Alpers's profile →
Citations per field
00.5×2×4×6×7.3×
Charles E. Alpers · 1×
Citations per year

Countries citing papers authored by Mark Haas

Since Specialization
Citations

This map shows the geographic impact of Mark Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Haas more than expected).

Fields of papers citing papers by Mark Haas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Haas. The network helps show where Mark Haas may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Haas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Haas Line = papers co-authored together Mark Haas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 288 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Hit paper breakdown →
20081600
2
Pathologic Classification of Diabetic Nephropathy
Hit paper breakdown →
20101307
3
VEGF Inhibition and Renal Thrombotic Microangiopathy
Hit paper breakdown →
20081284
4
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
Hit paper breakdown →
20141158
5
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
Hit paper breakdown →
20091023
6
Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)
Hit paper breakdown →
2007904
7
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
Hit paper breakdown →
2017895
8
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
Hit paper breakdown →
2009863
9
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
Hit paper breakdown →
2017828
10
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
Hit paper breakdown →
2018758
11
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
Hit paper breakdown →
2020639
12
Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups
Hit paper breakdown →
2010628
13
A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
Hit paper breakdown →
2018576
14
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
Hit paper breakdown →
2016537
15
C3 glomerulopathy: consensus report
Hit paper breakdown →
2013497
16
IgA Nephropathy
Hit paper breakdown →
2017406
17 1997381
18 1997352
19 2000349
20
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
Hit paper breakdown →
2012334

About Mark Haas

Mark Haas is a scholar working on Transplantation, Nephrology, Immunology, Rheumatology and Molecular Biology, having authored 288 papers that have together received 30.4k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (102 papers), Renal Diseases and Glomerulopathies (89 papers), Complement system in diseases (28 papers), Ion Transport and Channel Regulation (25 papers), Systemic Lupus Erythematosus Research (24 papers), Chronic Kidney Disease and Diabetes (11 papers), Acute Kidney Injury Research (8 papers) and Transplantation: Methods and Outcomes (6 papers). The work is most often cited by research in Transplantation (10.7k citations), Nephrology (9.7k citations), Rheumatology (2k citations), Immunology (2.5k citations) and Molecular Biology (2.7k citations). Mark Haas has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Bliss Forbush, Richard John Quigg, Benjamin H. Spargo, Shane M. Meehan, Lorraine C. Racusen, Lihua Bao, Ingeborg M. Bajema, Charles E. Alpers, Jan A. Bruijn and Surya V. Seshan. Their work appears in journals such as Kidney International, American Journal of Transplantation, Transplantation, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact